Ilaprazole

Ilaprazole
Clinical data
Trade names Noltec
Routes of
administration
Oral
ATC code None
Identifiers
CAS Number 172152-36-2
PubChem (CID) 214351
ChemSpider 185839
UNII 776Q6XX45J YesY
ChEMBL CHEMBL2106370
Chemical and physical data
Formula C19H18N4O2S
Molar mass 366.436820 g/mol
3D model (Jmol) Interactive image

Ilaprazole (trade name Noltec) is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and duodenal ulcer. It is available in strengths of 5, 10, and 20 mg.

Clinical studies show that ilaprazole is at least as potent a PPI as omeprazole when taken in equivalent doses. Studies also showed that ilaprazole significantly prevented the development of reflux oesophagitis.

Ilaprazole is developed by Il-Yang Pharmaceutical (Korea), and is still under clinical trials with US FDA. It has launched in Korea and China for the treatment of gastric ulcer, duodenal ulcer, gastroesophageal reflux disease and erosive esophagitis.[1]

References

This article is issued from Wikipedia - version of the 7/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.